메뉴 건너뛰기




Volumn 20, Issue 3, 2013, Pages 397-408

Safety and immunogenicity of DNA prime and modified vaccinia ankara virus-HIV subtype c vaccine boost in healthy adults

Author keywords

[No Author keywords available]

Indexed keywords

ADVAX; CYTOKINE; DNA VACCINE; GAMMA INTERFERON; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; PLACEBO; RECOMBINANT MODIFIED VACCINIA VIRUS ANKARA VACCINE; RECOMBINANT VACCINE; TBC M 4; UNCLASSIFIED DRUG;

EID: 84875023728     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00637-12     Document Type: Article
Times cited : (25)

References (56)
  • 1
    • 79957604683 scopus 로고    scopus 로고
    • Thirty years of hiv and aids: Future challenges and opportunities. Ann. Intern. Med. 154:766-771. 2. Excler jl, rida w, priddy fh, gilmour j, mcdermott ab, kamali a, anzala o, mutua g, sanders ej, koff w, berkley s, fast pe. 2011. Aids vaccines and pre-exposure prophylaxis: Is synergy possible?
    • Dieffenbach CW, Fauci AS. 2011. Thirty years of HIV and AIDS: future challenges and opportunities. Ann. Intern. Med. 154:766-771. 2. Excler JL, Rida W, Priddy FH, Gilmour J, McDermott AB, Kamali A, Anzala O, Mutua G, Sanders EJ, Koff W, Berkley S, Fast PE. 2011. AIDS vaccines and pre-exposure prophylaxis: is synergy possible? AIDS Res. Hum. Retroviruses 27:669-680.
    • (2011) AIDS Res. Hum. Retroviruses , vol.27 , pp. 669-680
    • Dieffenbach, C.W.1    Fauci, A.S.2
  • 2
    • 78649358100 scopus 로고    scopus 로고
    • Lessons drawn from recent hiv vaccine efficacy trials. J. Acquir. Immune defic. Syndr. 55(suppl 2):s128-s131. 4. Girard mp, osmanov s, assossou om, kieny mp. 2011. Human immunodeficiency virus (hiv) immunopathogenesis and vaccine development: A review
    • Fuchs JD, Sobieszczyk ME, Hammer SM, Buchbinder SP. 2010. Lessons drawn from recent HIV vaccine efficacy trials. J. Acquir. Immune Defic. Syndr. 55(Suppl 2):S128-S131. 4. Girard MP, Osmanov S, Assossou OM, Kieny MP. 2011. Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review. Vaccine 29:6191-6218.
    • (2010) Vaccine , vol.29 , pp. 6191-6218
    • Fuchs, J.D.1    Sobieszczyk, M.E.2    Hammer, S.M.3    Buchbinder, S.P.4
  • 4
    • 77958490167 scopus 로고    scopus 로고
    • Induction of immunity to human immunodeficiency virus type-1 by vaccination
    • McElrath MJ, Haynes BF. 2010. Induction of immunity to human immunodeficiency virus type-1 by vaccination. Immunity 33:542-554.
    • (2010) Immunity , vol.33 , pp. 542-554
    • McElrath, M.J.1    Haynes, B.F.2
  • 6
    • 77955518218 scopus 로고    scopus 로고
    • Attenuated poxvirus vectors mva and nyvac as promising vaccine candidates against hiv/aids. Hum. Vaccines 5:867-871. 9. Pantaleo g, esteban m, jacobs b, tartaglia j. 2010. Poxvirus vectorbased hiv vaccines
    • Esteban M. 2009. Attenuated poxvirus vectors MVA and NYVAC as promising vaccine candidates against HIV/AIDS. Hum. Vaccines 5:867-871. 9. Pantaleo G, Esteban M, Jacobs B, Tartaglia J. 2010. Poxvirus vectorbased HIV vaccines. Curr. Opin. HIV AIDS 5:391-396.
    • (2009) Curr. Opin. HIV AIDS , vol.5 , pp. 391-396
    • Esteban, M.1
  • 8
    • 84858294842 scopus 로고    scopus 로고
    • Biosafety aspects of modified vaccinia virus ankara (mva)-based vectors used for gene therapy or vaccination
    • Verheust C, Goossens M, Pauwels K, Breyer D. 2012. Biosafety aspects of modified vaccinia virus Ankara (MVA)-based vectors used for gene therapy or vaccination. Vaccine 30:2623-2632.
    • (2012) Vaccine , vol.30 , pp. 2623-2632
    • Verheust, C.1    Goossens, M.2    Pauwels, K.3    Breyer, D.4
  • 18
    • 84860337949 scopus 로고    scopus 로고
    • Dna and modified vaccinia ankara (mva) human immunodeficiency virus type 1 (hiv-1) vaccines encoding multiple cytotoxic and helper t-lymphocyte epitopes are safe but weakly immunogenic in hiv-1-uninfected, vaccinia-naive adults
    • Gorse GJ, Newman MJ, Decamp A, Hay CM, De Rosa SC, Noonan E, Livingston BD, Fuchs JD, Kalams SA, Cassis-Ghavami FL. 2012. DNA and modified vaccinia Ankara (MVA) human immunodeficiency virus type 1 (HIV-1) vaccines encoding multiple cytotoxic and helper T-lymphocyte epitopes are safe but weakly immunogenic in HIV-1-uninfected, vaccinia-naive adults. Clin. Vaccine Immunol. 19:649-658.
    • (2012) Clin. Vaccine Immunol , vol.19 , pp. 649-658
    • Gorse, G.J.1    Newman, M.J.2    Decamp, A.3    Hay, C.M.4    De Rosa, S.C.5    Noonan, E.6    Livingston, B.D.7    Fuchs, J.D.8    Kalams, S.A.9    Cassis-Ghavami, F.L.10
  • 28
    • 79953170206 scopus 로고    scopus 로고
    • Long-term control of simian immunodeficiency virus mac251 viremia to undetectable levels in half of infected female rhesus macaques nasally vaccinated with simian immunodeficiency virus dna/recombinant modified vaccinia virus ankara
    • Manrique M, Kozlowski PA, Cobo-Molinos A, Wang SW, Wilson RL, Montefiori DC, Mansfield KG, Carville A, Aldovini A. 2011. Long-term control of simian immunodeficiency virus mac251 viremia to undetectable levels in half of infected female rhesus macaques nasally vaccinated with simian immunodeficiency virus DNA/recombinant modified vaccinia virus Ankara. J. Immunol. 186:3581-3593.
    • (2011) J. Immunol , vol.186 , pp. 3581-3593
    • Manrique, M.1    Kozlowski, P.A.2    Cobo-Molinos, A.3    Wang, S.W.4    Wilson, R.L.5    Montefiori, D.C.6    Mansfield, K.G.7    Carville, A.8    Aldovini, A.9
  • 32
    • 78650531619 scopus 로고    scopus 로고
    • Living in a house of cards: Re-evaluating cd8-t-cell immune correlates against hiv
    • Makedonas G, Betts MR. 2011. Living in a house of cards: re-evaluating CD8-T-cell immune correlates against HIV. Immunol. Rev. 239:109-124.
    • (2011) Immunol. Rev , vol.239 , pp. 109-124
    • Makedonas, G.1    Betts, M.R.2
  • 33
    • 40549120282 scopus 로고    scopus 로고
    • Design, construction, and characterization of a dual-promoter multigenic dna vaccine directed against an hiv-1 subtype c/b' recombinant
    • Huang Y, Chen Z, Zhang W, Gurner D, Song Y, Gardiner DF, Ho DD. 2008. Design, construction, and characterization of a dual-promoter multigenic DNA vaccine directed against an HIV-1 subtype C/B' recombinant. J. Acquir. Immune Defic. Syndr. 47:403-411. 37. Vasan S, Schlesinger SJ, Huang Y, Hurley A, Lombardo A, Chen Z, Than S, Adesanya P, Bunce C, Boaz M, Boyle R, Sayeed E, Clark L, Dugin D, Schmidt C, Song Y, Seamons L, Dally L, Ho M, Smith C, Markowitz M, Cox J, Gill DK, Gilmour J, Keefer MC, Fast P, Ho DD. 2010. Phase 1 safety and immunogenicity evaluation of ADVAX, a multigenic, DNA-based clade C/B' HIV-1 candidate vaccine. PLoS One 5:e8617. doi:10.1371/journal.pone. 0008617.
    • (2008) J. Acquir. Immune Defic. Syndr , vol.47 , pp. 403-411
    • Huang, Y.1    Chen, Z.2    Zhang, W.3    Gurner, D.4    Song, Y.5    Gardiner, D.F.6    Ho, D.D.7
  • 34
    • 33750702683 scopus 로고    scopus 로고
    • ISBN 978-1-904610-00-7. BARQA, Ipswich, United Kingdom. 39. Vasan S, Hurley A, Schlesinger SJ, Hannaman D, Gardiner DF, Dugin DP, Boente-Carrera M, Vittorino R, Caskey M, Andersen J, Huang Y, Cox JH, Tarragona-Fiol T, Gill DK, Cheeseman H, Clark L, Dally L, Smith C, Schmidt C, Park HH, Kopycinski JT, Gilmour J, Fast P, Bernard R, Ho DD. 2011. Electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteers. PLoS One 6:e19252. doi:10.1371/journal.pone.0019252
    • Stiles T, Grant V. 2011. Good clinical laboratory practice (GCLP). A quality system for laboratories that undertake the analysis of samples from clinical trials, p 1-18. ISBN 978-1-904610-00-7. BARQA, Ipswich, United Kingdom. 39. Vasan S, Hurley A, Schlesinger SJ, Hannaman D, Gardiner DF, Dugin DP, Boente-Carrera M, Vittorino R, Caskey M, Andersen J, Huang Y, Cox JH, Tarragona-Fiol T, Gill DK, Cheeseman H, Clark L, Dally L, Smith C, Schmidt C, Park HH, Kopycinski JT, Gilmour J, Fast P, Bernard R, Ho DD. 2011. Electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteers. PLoS One 6:e19252. doi:10.1371/journal.pone.0019252.
    • (2011) Good Clinical Laboratory Practice (GCLP). A quality system for laboratories that undertake the Analysis of Samples from Clinical Trials , pp. 1-18
    • Stiles, T.1    Grant, V.2
  • 41
    • 77951695279 scopus 로고    scopus 로고
    • Dna vaccines: Developing new strategies against cancer
    • doi:10.1155/2010/174378
    • Fioretti D, Iurescia S, Fazio VM, Rinaldi M. 2010. DNA vaccines: developing new strategies against cancer. J. Biomed. Biotechnol. 2010: 174378. doi:10.1155/2010/174378.
    • (2010) J. Biomed. Biotechnol , Issue.2010 , pp. 174378
    • Fioretti, D.1    Iurescia, S.2    Fazio, V.M.3    Rinaldi, M.4
  • 49
    • 84863774072 scopus 로고    scopus 로고
    • Broadly neu-tralizing antibodies present new prospects to counter highly antigenically diverse viruses
    • Burton DR, Poignard P, Stanfield RL, Wilson IA. 2012. Broadly neu-tralizing antibodies present new prospects to counter highly antigenically diverse viruses. Science 337:183-186.
    • (2012) Science , vol.337 , pp. 183-186
    • Burton, D.R.1    Poignard, P.2    Stanfield, R.L.3    Wilson, I.A.4
  • 50
    • 84861986980 scopus 로고    scopus 로고
    • Hiv vaccine development: Challenges and opportunities towards solving the hiv vaccine-neutralizing antibody problem
    • Koff WC. 2012. HIV vaccine development: challenges and opportunities towards solving the HIV vaccine-neutralizing antibody problem. Vaccine 30:4310-4315.
    • (2012) Vaccine , vol.30 , pp. 4310-4315
    • Koff, W.C.1
  • 51
    • 82955241840 scopus 로고    scopus 로고
    • Rational design of vaccines to elicit broadly neutralizing antibodies to hiv-1
    • doi:10.1101/cshperspect.a007278
    • Kwong PD, Mascola JR, Nabel GJ. 2011. Rational design of vaccines to elicit broadly neutralizing antibodies to HIV-1. Cold Spring Harbor Perspect. Med. 1:a007278. doi:10.1101/cshperspect.a007278.
    • (2011) Cold Spring Harbor Perspect. Med , Issue.1
    • Kwong, P.D.1    Mascola, J.R.2    Nabel, G.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.